share_log

300亿券商股拟购买民生证券100%股份 明起复牌|盘后公告集锦

30 billion brokerage shares plan to buy 100% of Minsheng Securities shares and resume trading tomorrow|Highlights of post-market announcements

cls.cn ·  May 14 20:13

Beijing Lier: Wholly-owned subsidiary plans to sell shares in Minsheng Securities and subscribe for shares issued by Guolian Securities

image

Today's focus

[League of Nations Securities: Intended to buy 100% of Minsheng Securities shares and resume trading tomorrow]

Guolian Securities announced that it plans to purchase 100% of their total shares in Minsheng Securities from 46 counterparties, including the League of Nations Group and Fengquanyu, and raise supporting capital by issuing A-shares. The price of this deal is yet to be determined. According to relevant regulations, trading of the company's shares will resume from the opening of the market on May 15.

[Beijing Lier: Wholly-owned subsidiary plans to sell shares in Minsheng Securities and subscribe for shares issued by Guolian Securities]

Beijing Lier announced that Luoyang Lier Refractory Co., Ltd., a wholly-owned subsidiary of the company, plans to sell 146.9577.1 million shares of Minsheng Securities Co., Ltd. to Guolian Securities, subscribe for additional A shares issued by Guolian Securities using the underlying assets, and sign a “Framework Agreement on Issuing Shares to Purchase Assets” with Guolian Securities.

[Times Publishing: Plans to sell 73.475 million shares of Minsheng Securities to Guolian Securities]

Times Publishing announced that it plans to sell 73.475 million shares of Minsheng Securities to Guolian Securities and use the underlying assets to subscribe for additional A-shares issued by Guolian Securities.

[Sophia: Wholly-owned subsidiary plans to sell 294 million shares of Minsheng Securities to Guolian Securities]

Sophia announced that its wholly-owned subsidiary Sophia Investment plans to sell 294 million shares of Minsheng Securities to Guolian Securities and use the underlying assets to subscribe for additional A-shares issued by Guolian Securities.

[Xinghu Technology: Yipin Group and Tie Xiaorong plan to reduce their total holdings by no more than 1%]

According to Xinghu Technology's announcement, Yipin Group and co-actor Tie Xiaorong intend to reduce their holdings through centralized bidding within 3 months of 15 trading days of the announcement. The company's shares will be reduced by no more than 16.614,700 shares, that is, the holdings will be reduced by no more than 1% of the company's total share capital.

Investments & Contracts

[Zhejiang Rongtai: Proposed construction of mica materials and composites project for new energy vehicles in Thailand]

Zhejiang Rongtai announced that the company plans to eventually invest in the construction of a project with an annual output of 18,000 tons of mica materials and new composite materials for new energy vehicles through the establishment of a subsidiary by Singapore Rongtai, a wholly-owned subsidiary in Thailand. The total investment of the project is estimated to be about 300 million yuan (equivalent to about US$42,2357 million).

[Huadian Heavy Industries: Plans to jointly invest with the controlling shareholder Science and Engineering Group to establish Guangdong Huadian Marine Technology and Huadian (Yangjiang) Offshore Operation and Maintenance]

Huadian Heavy Industries announced that the company and the controlling shareholder Science and Engineering Group intend to jointly invest in the establishment of Guangdong Huadian Marine Energy Technology Co., Ltd. (tentative name, based on the name finally approved by the market supervision and administration department, hereinafter referred to as “Guangdong Huadian Marine Technology”) and Huadian (Yangjiang) Offshore Wind Power Operation and Maintenance Co., Ltd. (provisional name, subject to the name finally approved by the market supervision and management department, hereinafter referred to as “Huadian (Yangjiang) Offshore Wind Operation and Maintenance”). Guangdong Huadian Marine Technology has a registered capital of 30,000 yuan, of which the company invested 21 million yuan, with a share ratio of 70%; Kegong Group invested 90 million yuan, with a share ratio of 30%; Huadian (Yangjiang) Haifeng Operation and Maintenance registered capital of 10,000 yuan, of which the company invested 70 million yuan, with a share ratio of 70%; Kegong Group invested 30 million yuan, with a share ratio of 30%.

[Shentong Technology: Proposed joint investment with related parties to establish a company]

Shentong Technology announced that the company plans to jointly fund the establishment of Ningbo Big Whale Film Co., Ltd. with Fang Lifeng, Zhu Chunya, Cheng Yuhai, and Jiang Jianming, with a registered capital of RMB 5 million, of which the company has pledged a capital of 1.75 million yuan, accounting for 35%.

Changes in equity

[Jilin Chemical Fiber: The actual controller is to be changed from the Jilin Municipal State-owned Assets Administration Commission to the Jilin Provincial State-owned Assets Administration Commission]

Jilin Chemical Fiber announced that the actual controller of the company, the Jilin Municipal State-owned Assets Administration Commission, plans to transfer control of Jilin Chemical Fiber Group and Jilin Guoxing New Materials Industry Investment Co., Ltd. to the operation of provincial state-owned capital. After the transaction is completed, the controlling shareholder of the company will remain the Chemical Fiber Group, the capital operation group will become the indirect controlling shareholder of the company, and the actual controller of the company will be changed from the Jilin Municipal State-owned Assets Administration Commission to the Jilin Provincial State-owned Assets Administration Commission.

[Fosun Pharmaceutical: Holding subsidiary signs agreement to increase capital and expand shares]

Fosun Pharmaceutical announced that its holding subsidiary Fosun Health signed a “Capital Increase Agreement” with Foshan Chanxi City Investment. According to the “Capital Increase Agreement”, Foshan Chanxi City Investment plans to designate entities (including funds, holding companies or other entities) to invest RMB 300 million to pledge Fosun Health's additional registered capital of RMB 156 million according to the pre-investment valuation of RMB 10.2 billion.

[Zhongbei Communications: Controlling shareholders and actual controllers plan to transfer 5% of the company's shares by agreement]

China Bay Communications announced that Li Liubing, the controlling shareholder and actual controller of the company, plans to transfer 5% of the company's shares to Shenzhen Baiyang Private Equity Fund. The transfer price is 26.11 yuan/share, and the transfer price is about 438 million yuan.

Increase/decrease holdings & repurchases

[Dongpeng Holdings: Shareholders plan to reduce their total holdings of the company by no more than 3%]

Dongpeng Holdings announced that SCC Holdco B and Shanghai Zhelde plan to reduce their total holdings of the company by no more than 3%.

[Jianzhijia: Suzhou and Ju Rongyi plan to reduce the company's shares by no more than 1% in total]

Jianzhijia announced that the company's shareholders Suzhou and JuRongyi Investment Partnership (“Suzhou Hejuyi”) and Suzhou Hejuhuiyi Investment Partnership (limited partnership) (“Suzhou Hejuhuiyi”) plan to reduce their total holdings of the company's shares by no more than 1.288,500 shares through collective bidding and bulk transactions within 3 months after 3 trading days, accounting for 1% of the company's total share capital. Suzhou and JuRongyi, Suzhou and Juhuiyi are all enterprises under the same control of Suzhou and Zheng Equity Investment Fund Management Enterprise (Limited Partnership).

[Maolai Optics: Plans to use overfunded capital of 25 million yuan to 50 million yuan to buy back the company's shares]

Mulai Optics announced that it plans to use the overfunded capital of 25 million yuan to 50 million yuan to repurchase the company's shares through centralized bidding transactions. The repurchase price will not exceed 162 yuan/share. The shares repurchased will be used for employee stock ownership plans or equity incentives at an appropriate time in the future.

[Xinghu Technology: Yipin Group and Tie Xiaorong plan to reduce their total holdings by no more than 1%]

According to Xinghu Technology's announcement, Yipin Group and co-actor Tie Xiaorong intend to reduce their holdings through centralized bidding within 3 months of 15 trading days of the announcement. The company's shares will be reduced by no more than 16.614,700 shares, that is, the holdings will be reduced by no more than 1% of the company's total share capital.

Operation & Performance

[Shenzhen Airport: Passenger throughput fell 0.11% year on year in April]

Shenzhen Airport announced that passenger throughput in April was 4.3079 million passengers, down 0.11% year on year; 30,700 flights took off and landed, down 3.7% year on year.

[Qianyuan Electric Power: Research on key technologies for energy-saving transformation of the company's buildings and put into operation of applied technology projects]

Qianyuan Electric Power announced that the company's key technology research and application technology project (hereinafter referred to as the “Project”) for energy saving transformation of buildings has been successfully put into operation. The project amount is 4,652.11 million yuan. Based on the actual construction facilities and energy usage structure of the Qianyuan Building, 78.1 kWp roof photovoltaics, 7.95 kWp curtain wall photovoltaics, 8 7kW AC charging piles, and 50 kW/200 kWh zinc-bromine liquid flow energy storage equipment were built to form an integrated optical storage and charging system.

[Huayang Co., Ltd.: Holding subsidiary Wenjiazhuang mining capacity increased to 5 million tons/year]

Huayang Co., Ltd. announced that the holding subsidiary of the company, Shanxi Pingshu Coal Co., Ltd. (“Pingshu Coal”) recently received documents from the Shanxi Provincial Energy Administration. The Shanxi Provincial Energy Administration has completed the registration of production capacity and production factor documentation for Pingshu Coal's Wenjiazhuang Mine in accordance with relevant requirements. The mine's production capacity has increased from 900,000 tons/year to 5 million tons/year.

Contract & Project Bid Winning

[Longquan Co., Ltd.: Won the bid for the second purchase of the Zhangwei South Canal to Machihe Camera Flooding Project (Phase I) in Xiajin County]

Longquan Co., Ltd. announced that the company won the bid for the second bid for the Zhangwei South Canal to Machihe Camera Flooding Project (Phase I) in Xiajin County. The winning bid price was RMB 94.294 million (tax included).

** [China Railway Construction: won bids for several major projects]

China Railway Construction announced that the company recently won bids for several major projects, with a total project amount of 61.154 billion yuan.

[Weihai Guangtai: won the bid for 375 million yuan special customer fire engine project]

Weihai Guangtai announced that Beijing Zhongzhuo Times Fire Equipment Technology Co., Ltd., a wholly-owned subsidiary, recently won the bid for a fire engine project and obtained a notice of winning the bid. The winning bid amount was 375 million yuan, accounting for 15.6% of the 2023 audited revenue.

[Jianghe Group: won the bid for the curtain wall subcontract project for the C1c-01 commercial office project in Zhangjiabang Wedge-shaped Greenland in Pudong New Area, Shanghai]

Jianghe Group announced that its wholly-owned subsidiary Shanghai Jianghe Façade System Engineering Co., Ltd. recently won the bid for the curtain wall subcontract project for the C1C-01 commercial office project in Zhangjiabang Wedge-shaped Greenland in Pudong New Area, Shanghai. The total bid amount was RMB 288,651,136, accounting for about 1.38% of the company's 2023 revenue.

Stock price changes

[Thinking and control: Currently, production and operation activities are normal, and there are no important matters that should be disclosed but not disclosed]

Mind Control issued an announcement of abnormal fluctuations in stock trading. The company's current production and operation activities are normal, the internal production order is normal, the company's main business has not undergone major changes, and there are no major matters that should be disclosed but not disclosed. After self-inspection by the company and written letters to the controlling shareholders and actual controllers of the company, as of the announcement date, the company, the controlling shareholders and actual controllers of the company had no significant matters affecting abnormal fluctuations in the company's stock transactions, nor any other important information that should have been disclosed but not disclosed.

[*ST Zhongdi: Recently, the company's business situation is normal, and there have been no major changes in the internal and external business environment]

*ST Zhongdi issued a change announcement. Recently, the company's business situation is normal, and there have been no major changes in the internal and external business environment. The company, controlling shareholders, and actual controllers have no important matters relating to the Company that should be disclosed but not disclosed, or that are in the planning stage.

[*ST Pharmaceuticals: There is a risk that the listing of the company's shares will be terminated]

*ST Pharmaceutical issued a notice of abnormal fluctuations in stock trading. The company's stock listing will be terminated by the Shanghai Stock Exchange due to the negative net profit before and after deducting non-recurring profit and loss in 2023, and the operating income after deducting business income unrelated to the main business and income with no commercial substance of less than 100 million yuan. If the company experiences any of the circumstances stipulated in section 9.3.12 of the “Shanghai Stock Exchange Stock Listing Rules” (revised in April 2024), the company's stock listing will be terminated by the Shanghai Stock Exchange.

other

[Wujin Stainless: Chairman Zhu Guoliang Resigns]

Wu Jinshi announced that Mr. Zhu Guoliang applied to resign from all positions including the company's chairman, director, audit committee member of the board of directors, and member of the board strategy committee due to age and physical reasons. After his resignation, Mr. Zhu Guoliang will no longer hold any position in the company.

[Shanghai Jiahua: Chairman Pan Qiusheng Resigns]

Shanghai Jiahua announced that the chairman of the board, Mr. Pan Qiusheng, resigned. Before the election of the new chairman, Mr. Cheng Jianxin, a director of the company, was selected as acting chairman of the company to perform the duties of chairman until the election of the new chairman.

[Tonghua Dongbao: Dugu Insulin Liraglutide Injection Phase I Clinical Trial Completed First Patient Administration]

Tonghua Dongbao announced that the Phase I clinical trial of Degu insulin liraglutide injection completed the first patient administration. Tokugu Insulin Liraglutide Injection is the world's first marketed compound formulation composed of a basic insulin analog and a GLP-1 analog. It groundbreaking combines the two-component advantages of the two drugs, complements the mechanisms, and acts in multiple targets on many pathophysiological mechanisms of type 2 diabetes to regulate glucose homeostasis.

[Huiyu Pharmaceutical: Cladribine injections, etc. have obtained drug registration certificates]

Huiyu Pharmaceutical announced that the company recently received the “Drug Registration Certificate” for cladribine injection and roxatidine hydrochloride acetate approved by the State Drug Administration. Cladribine injection and roxatidine hydrochloride acetate for injection are registered and classified as 3 types of chemicals. They were reviewed and approved according to technical requirements consistent with the quality and efficacy of the reference preparation. After approval, it is treated as if they have passed the consistent evaluation of the quality and efficacy of generic drugs. The cladribine injection approved by the company this time is the first company in China to be deemed to have passed the consistency evaluation.

[Warner Pharmaceuticals: Subsidiary pharmaceutical ingredient lanthanum carbonate obtained approval notice for listing application]

Warner Pharmaceuticals announced that its subsidiary pharmaceutical ingredient, lanthanum carbonate, has obtained a notice of approval for the listing application. Lanthanum carbonate is used to treat hyperphosphatemia. The activity of lanthanum carbonate as a phosphorus binder depends on the high affinity of lanthanum ions with phosphate. Lanthanum ions are released from carbonate in an acidic environment in the stomach and bind to phosphorus in food to form insoluble lanthanum phosphate, thereby reducing the absorption of phosphorus in the gastrointestinal tract.

[Sinopharm Hyundai: Subsidiary Receives Registration Certificate for Paramivir Injection]

Sinopharm Hyundai announced that recently, Sinopharm Rongsheng, a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” for paramivir injections approved and issued by the State Drug Administration. Paramivir is a new generation neuraminidase inhibitor that selectively inhibits the neuraminidase of human influenza A and B viruses, thereby inhibiting the spread of influenza virus in humans to treat influenza.

[China Pharmaceutical: Chairman Li Yadong and Vice Chairman Wang Xiao resign]

China Pharmaceutical announced that due to job adjustments, Mr. Li Yadong applied for the resignation of the company's chairman (legal representative), director and relevant positions in the special committee of the board of directors. Due to job adjustments, Mr. Wang Xiao applied to resign as vice chairman and director of the company.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment